This work was supported by the French Government under the “Investments for the Future” programme managed by the National Agency for Research (ANR), Méditerranée-Infection 10-IAHU-03. Testing of repatriates was approved by the ethical board of the Committee for the Protection of Persons (CPP Ile de France VI dated 06–02–2020).